GI Innovation (XKRX:358570) FCF Yield % : -9.54 (As of Jun. 18, 2024)

View and export this data going back to 2023. Start your Free Trial

What is GI Innovation FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, GI Innovation's Trailing 12-Month Free Cash Flow is ₩-43,175 Mil, and Market Cap is ₩452,410 Mil. Therefore, GI Innovation's FCF Yield % for today is -9.54%.

The historical rank and industry rank for GI Innovation's FCF Yield % or its related term are showing as below:

XKRX:358570' s FCF Yield % Range Over the Past 10 Years
Min: -18.12 Med: -8.45 Max: -6.21
Current: -9.54

During the past 5 years, the highest FCF Yield % of GI Innovation was -6.21%. The lowest was -18.12%. And the median was -8.45%.

XKRX:358570's FCF Yield % is ranked better than
59.03% of 1550 companies
in the Biotechnology industry
Industry Median: -14.22 vs XKRX:358570: -9.54

GI Innovation's FCF Margin % for the quarter that ended in Mar. 2024 was -47,709.65%.

GI Innovation FCF Yield % Historical Data

The historical data trend for GI Innovation's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GI Innovation FCF Yield % Chart

GI Innovation Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Yield %

GI Innovation Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial												-10.07	-14.08	-7.31	-4.59	-7.95

Competitive Comparison of GI Innovation's FCF Yield %

For the Biotechnology subindustry, GI Innovation's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GI Innovation's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GI Innovation's FCF Yield % distribution charts can be found below:

* The bar in red indicates where GI Innovation's FCF Yield % falls into.

GI Innovation FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

GI Innovation's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-65520.301	/	0
	=	N/A%

GI Innovation's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-11584.379	*	4	/	583057.696
	=	-7.95%

GI Innovation FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

GI Innovation FCF Yield % Related Terms

Thank you for viewing the detailed overview of GI Innovation's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

GI Innovation (XKRX:358570) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GI Innovation Inc (XKRX:358570) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Songpa-daero 167, Room 1116 of A-dong, Songpa-gu, Seoul, KOR, 05855

Website

https://www.gi-innovation.com

GI Innovation Inc is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART platform.

GI Innovation (XKRX:358570) Headlines

No Headlines